Observation of Ziprasidone and risperidone in the treatment of female patients with schizophrenia

SUN Wei,MA Shi-fa,LI Ya-jun
DOI: https://doi.org/10.3969/j.issn.1674-4985.2011.06.049
2011-01-01
Abstract:Objective To investigate the efficacy and safety of ziprasidone and risperidone in the treatment of female patients with schizophrenia.Methods 100 female inpatients with schizophrenia were randomly divided into groups ziprasidone and risperidone group,with 50 cases in each group.To assess the clinical treatment of the symptoms to Scale(TESS)assess adverse reactions with positive and negative syndrome scale(PANSS),the quality of life was assessed by the World Health Organization Quality of Life Scale(WHO QOL-100),and body weight,blood glucose and prolactin were testes.Results Two groups showed considerable overall effect;risperidone caused more extrapyramidal effects of ziprasidone and a high incidence of anticholinergic effects;ziprasidone on serum prolactin,blood glucose,body mass of small compared risperidone;ziprasidone group WHOQOL- 100 scores were significantly improved in all areas.Conclusion The efficacy of ziprasidone is same as risperidone,with lower side effects,and can improve the quality of life.
What problem does this paper attempt to address?